Oxyntomodulin increases intrinsic heart rate in mice independent of the glucagon-like peptide-1 receptor
- 1 February 2007
- journal article
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 292 (2), R962-R970
- https://doi.org/10.1152/ajpregu.00405.2006
Abstract
Oxyntomodulin (OXM), a postprandially released intestinal hormone, inhibits food intake via the glucagon-like peptide-1 receptor (GLP-1R). Although OXM may have clinical value in treating obesity, the cardiovascular effects of OXM are not well understood. Using telemetry to measure heart rate (HR), body temperature (Tb), and activity in conscious and freely moving mice, we tested 1 ) whether OXM affects HR and 2 ) whether this effect is mediated by the GLP-1R. We found that peripherally administered OXM significantly increased HR in wild-type mice, raising HR by >200 beats/min to a maximum of 728 ± 11 beats/min. To determine the extent to which the sympathetic nervous system mediates the tachycardia of OXM, we delivered this hormone to mice deficient in dopamine-β-hydroxylase [ Dbh (−/−) mice], littermate controls [ Dbh (+/−) mice], and autonomically blocked C57Bl mice. OXM increased HR equally in all groups (192 ± 13, 197 ± 21, and 216 ± 11 beats/min, respectively), indicating that OXM elevated intrinsic HR. Intrinsic HR was also vigorously elevated by OXM in Glp-1R (−/−) mice (200 ± 28 beats/min). In addition, peripherally administered OXM inhibited food intake and activity levels in wild-type mice and lowered Tb in autonomically blocked mice. None of these effects were observed in Glp-1R (−/−) mice. These data suggest multiple modes of action of OXM: 1 ) it directly elevates murine intrinsic HR through a GLP-1R-independent mechanism, perhaps via the glucagon receptor or an unidentified OXM receptor, and 2 ) it lowers food intake, activity, and Tb in a GLP-1R-dependent fashion.Keywords
This publication has 50 references indexed in Scilit:
- OxyntomodulinCurrent Opinion in Endocrinology, Diabetes and Obesity, 2006
- Appetite controlJournal of Endocrinology, 2005
- Continuous measurements of plasma protein extravasation with microdialysis after various inflammatory challenges in rat and mouse skinAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Oxyntomodulin Inhibits Pancreatic Secretion Through the Nervous System in RatsPancreas, 2000
- ENTEROGLUCAGONAnnual Review of Physiology, 1997
- Glucagon-like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamusEndocrinology, 1996
- Cloning and sequence analysis of the murine glucagon receptor-encoding geneGene, 1995
- Tissue‐specific expression of the human receptor for glucagon‐like peptide‐I: brain, heart and pancreatic forms have the same deduced amino acid sequencesFEBS Letters, 1995
- Oxyntomodulin (glucagon-37) and its C-terminal octapeptide inhibit gastric acid secretionFEBS Letters, 1985
- Isolation of glucagon‐37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno‐ileumFEBS Letters, 1982